Catalent Inc (CTLT)
56.00
+0.15
(+0.27%)
USD |
NYSE |
May 01, 16:00
56.02
+0.02
(+0.03%)
Pre-Market: 20:00
Catalent Gross Profit Margin (Quarterly): 16.70% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.70% |
September 30, 2023 | 17.21% |
June 30, 2023 | 20.38% |
March 31, 2023 | 17.36% |
December 31, 2022 | 33.68% |
September 30, 2022 | 25.24% |
June 30, 2022 | 35.90% |
March 31, 2022 | 33.23% |
December 31, 2021 | 33.28% |
September 30, 2021 | 31.61% |
June 30, 2021 | 36.95% |
March 31, 2021 | 34.76% |
December 31, 2020 | 32.71% |
September 30, 2020 | 29.43% |
June 30, 2020 | 35.29% |
March 31, 2020 | 31.40% |
December 31, 2019 | 32.19% |
September 30, 2019 | 26.73% |
June 30, 2019 | 35.33% |
March 31, 2019 | 32.18% |
December 31, 2018 | 32.33% |
September 30, 2018 | 26.91% |
June 30, 2018 | 34.06% |
Date | Value |
---|---|
March 31, 2018 | 30.53% |
December 31, 2017 | 30.91% |
September 30, 2017 | 25.76% |
June 30, 2017 | 34.88% |
March 31, 2017 | 31.43% |
December 31, 2016 | 30.58% |
September 30, 2016 | 28.06% |
June 30, 2016 | 35.29% |
March 31, 2016 | 28.81% |
December 31, 2015 | 33.44% |
September 30, 2015 | 28.72% |
June 30, 2015 | 35.62% |
March 31, 2015 | 34.08% |
December 31, 2014 | 34.25% |
September 30, 2014 | 29.95% |
June 30, 2014 | 36.62% |
March 31, 2014 | 33.48% |
December 31, 2013 | 31.18% |
September 30, 2013 | 28.77% |
June 30, 2013 | 34.38% |
March 31, 2013 | 30.74% |
December 31, 2012 | 32.10% |
September 30, 2012 | 28.52% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
16.70%
Minimum
Dec 2023
36.95%
Maximum
Jun 2021
29.44%
Average
32.19%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
Eli Lilly and Co | 80.91% |
Merck & Co Inc | 77.56% |
Elanco Animal Health Inc | 50.14% |
Avrobio Inc | -- |
Karuna Therapeutics Inc (DELISTED) | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -29.93% |
Return on Assets | -12.34% |
Return on Invested Capital | -14.07% |
Profit Margin (Quarterly) | -20.12% |
Operating Margin (Quarterly) | -11.13% |
Return on Net Operating Assets | -13.23% |